Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin,resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice
Ss. Hecht et al., Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin,resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice, CANCER LETT, 137(2), 1999, pp. 123-130
The potential activities of butylated hydroxyanisole (BHA), myo-inositol, c
urcumin, esculetin, resveratrol and lycopene-enriched tomato oleoresin (LTO
) as chemopreventive agents against lung tumor induction in A/J mice by the
tobacco smoke carcinogens benzo[a]pyrene (BaP) and 4-(methyl-nitrosamino)-
1-(3-pyridyl)-1-butanone (NNK) were evaluated. Groups of 20 A/J mice were t
reated weekly by gavage with a mixture of BaP and NNK (3 mu mol each) for 8
weeks, then sacrificed 26 weeks after the first carcinogen treatment. Mice
treated with BHA (20 or 40 mu mol) by gavage 2 h before each dose of BaP a
nd NNK had significantly reduced lung tumor multiplicity, Treatment with BH
A (20 or 40 mu mol) by gavage weekly or with dietary BHA (2000 ppm), curcum
in (2000 ppm) or resveratrol (500 ppm) from 1 week after carcinogen treatme
nt until termination had no effect on lung tumor multiplicity. Treatment wi
th dietary myo-inositol (30 000 ppm) or esculetin (2000 ppm) from 1 week af
ter carcinogen treatment until termination significantly reduced lung tumor
multiplicity, with the effect of myo-inositol being significantly greater
than that of esculetin. Treatment with dietary LTO (167, 1667 or 8333 ppm)
from I week before carcinogen treatment until termination had no effect on
lung tumor multiplicity. The results of this study demonstrate that BHA is
an effective inhibitor of BaP plus NNK-induced lung tumorigenesis in A/J mi
ce when administered during the period of carcinogen treatment and that, am
ong the compounds tested, myo-inositol is most effective after carcinogen t
reatment. (C) 1999 Published by Elsevier Science Ltd. All rights reserved.